<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" media="screen" href="/~d/styles/rss1full.xsl"?><?xml-stylesheet type="text/css" media="screen" href="http://feeds.nature.com/~d/styles/itemcontent.css"?><rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns="http://purl.org/rss/1.0/" xmlns:admin="http://webns.net/mvcb/" xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0">
<channel rdf:about="http://www.nature.com/nrrheum/current_issue/rss">
<title>Nature Reviews Rheumatology - AOP - nature.com science feeds</title>
<description>Nature Reviews Rheumatology provides physicians and academics with authoritative and topical discussions of key developments in the field.</description>
<link>http://www.nature.com/nrrheum/current_issue/</link>
<admin:generatorAgent rdf:resource="http://www.nature.com/" />
<admin:errorReportsTo rdf:resource="mailto:feedback@nature.com" />
<dc:publisher>Nature Publishing Group</dc:publisher>
<dc:language>en</dc:language>
<dc:rights>©  Nature Publishing Group</dc:rights>
<prism:publicationName>Nature Reviews Rheumatology</prism:publicationName>
<prism:issn>1759-4790</prism:issn>
<prism:eIssn>1759-4804</prism:eIssn>
<prism:copyright>©  Nature Publishing Group</prism:copyright>
<prism:rightsAgent>permissions@nature.com</prism:rightsAgent>
<image rdf:resource="http://www.nature.com/includes/rj_globnavimages/nrrheum_logo.gif" />
<items>
<rdf:Seq>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nrrheum.2009.227" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nrrheum.2009.228" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nrrheum.2009.219" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nrrheum.2009.217" />
</rdf:Seq>
</items>
<atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" href="http://feeds.nature.com/nrrheum/rss/aop" type="application/rss+xml" /><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="hub" href="http://pubsubhubbub.appspot.com" /></channel>
<image rdf:about="http://www.nature.com/includes/rj_globnavimages/nrrheum_logo.gif">
<title>Nature Reviews Rheumatology</title>
<url>http://www.nature.com/includes/rj_globnavimages/nrrheum_logo.gif</url>
<link>http://www.nature.com/nrrheum/</link>
</image>
<item rdf:about="http://dx.doi.org/10.1038/nrrheum.2009.227">
<title>Using ultrasonography to facilitate best practice in diagnosis and management of RA</title>
<link>http://feeds.nature.com/~r/nrrheum/rss/aop/~3/wMYJNzPetng/nrrheum.2009.227</link>
<description>Musculoskeletal ultrasonography is emerging as a potentially useful tool for the assessment and management of patients with rheumatoid arthritis. In this Review, Dr. Andrew Brown describes the diverse applications and advantages of this imaging modality in the diagnosis, treatment and monitoring of rheumatoid arthritis in the clinic.</description>
<content:encoded><![CDATA[

<p>
<b>Using ultrasonography to facilitate best practice in diagnosis and management of RA</b>
</p>
<p>Nature Reviews Rheumatology. <a href="http://dx.doi.org/10.1038/nrrheum.2009.227">doi:10.1038/nrrheum.2009.227</a>
</p>
<p>Author: Andrew K. Brown</p>
<img src="http://feeds.feedburner.com/~r/nrrheum/rss/aop/~4/wMYJNzPetng" height="1" width="1"/>]]></content:encoded>
<dc:title>Using ultrasonography to facilitate best practice in diagnosis and management of RA</dc:title>
<dc:creator>Andrew K. Brown</dc:creator>
<dc:identifier>doi:10.1038/nrrheum.2009.227</dc:identifier>
<dc:source>Nature Reviews Rheumatology</dc:source>
<dc:date>2009-11-10</dc:date>
<prism:publicationName>Nature Reviews Rheumatology</prism:publicationName>
<prism:publicationDate>2009-11-10</prism:publicationDate>
<prism:doi>10.1038/nrrheum.2009.227</prism:doi>
<prism:url>http://dx.doi.org/10.1038/nrrheum.2009.227</prism:url>
<prism:section>Review</prism:section>
<prism:startingPage />
<prism:endingPage />
<feedburner:origLink>http://dx.doi.org/10.1038/nrrheum.2009.227</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/nrrheum.2009.228">
<title>Cell-free and cell-based approaches for bone regeneration</title>
<link>http://feeds.nature.com/~r/nrrheum/rss/aop/~3/T1FiC7V1VvE/nrrheum.2009.228</link>
<description>The authors provide an overview of the current status of the rapidly progressing field of bone regeneration. Current approaches to bone regeneration at the level of the scaffold, cells, and growth factors are described, and the advantages and limitation of each approach are identified.</description>
<content:encoded><![CDATA[

<p>
<b>Cell-free and cell-based approaches for bone regeneration</b>
</p>
<p>Nature Reviews Rheumatology. <a href="http://dx.doi.org/10.1038/nrrheum.2009.228">doi:10.1038/nrrheum.2009.228</a>
</p>
<p>Authors: Ericka M. Bueno &amp; Julie Glowacki</p>
<img src="http://feeds.feedburner.com/~r/nrrheum/rss/aop/~4/T1FiC7V1VvE" height="1" width="1"/>]]></content:encoded>
<dc:title>Cell-free and cell-based approaches for bone regeneration</dc:title>
<dc:creator>Ericka M. Bueno</dc:creator>
<dc:creator>Julie Glowacki</dc:creator>
<dc:identifier>doi:10.1038/nrrheum.2009.228</dc:identifier>
<dc:source>Nature Reviews Rheumatology</dc:source>
<dc:date>2009-11-10</dc:date>
<prism:publicationName>Nature Reviews Rheumatology</prism:publicationName>
<prism:publicationDate>2009-11-10</prism:publicationDate>
<prism:doi>10.1038/nrrheum.2009.228</prism:doi>
<prism:url>http://dx.doi.org/10.1038/nrrheum.2009.228</prism:url>
<prism:section>Review</prism:section>
<prism:startingPage />
<prism:endingPage />
<feedburner:origLink>http://dx.doi.org/10.1038/nrrheum.2009.228</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/nrrheum.2009.219">
<title>Vascular effects of biologic agents in RA and spondyloarthropathies</title>
<link>http://feeds.nature.com/~r/nrrheum/rss/aop/~3/Zqa9gnq4abA/nrrheum.2009.219</link>
<description>Evidence is mounting that biologic agents used to treat rheumatoid arthritis and other inflammatory rheumatic diseases exert substantial effects not only on underlying inflammation but also on the vasculature. This article reviews the available evidence on the effects of infliximab, adalimumab, etanercept and rituximab on atherosclerosis and cardiovascular disease risk.</description>
<content:encoded><![CDATA[

<p>
<b>Vascular effects of biologic agents in RA and spondyloarthropathies</b>
</p>
<p>Nature Reviews Rheumatology. <a href="http://dx.doi.org/10.1038/nrrheum.2009.219">doi:10.1038/nrrheum.2009.219</a>
</p>
<p>Authors: Zolt&#225;n Szekanecz, Gy&#246;rgy Kerekes &amp; P&#225;l Solt&#233;sz</p>
<img src="http://feeds.feedburner.com/~r/nrrheum/rss/aop/~4/Zqa9gnq4abA" height="1" width="1"/>]]></content:encoded>
<dc:title>Vascular effects of biologic agents in RA and spondyloarthropathies</dc:title>
<dc:creator>Zoltán Szekanecz</dc:creator>
<dc:creator>György Kerekes</dc:creator>
<dc:creator>Pál Soltész</dc:creator>
<dc:identifier>doi:10.1038/nrrheum.2009.219</dc:identifier>
<dc:source>Nature Reviews Rheumatology</dc:source>
<dc:date>2009-11-10</dc:date>
<prism:publicationName>Nature Reviews Rheumatology</prism:publicationName>
<prism:publicationDate>2009-11-10</prism:publicationDate>
<prism:doi>10.1038/nrrheum.2009.219</prism:doi>
<prism:url>http://dx.doi.org/10.1038/nrrheum.2009.219</prism:url>
<prism:section>Review</prism:section>
<prism:startingPage />
<prism:endingPage />
<feedburner:origLink>http://dx.doi.org/10.1038/nrrheum.2009.219</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/nrrheum.2009.217">
<title>Osteoimmunology and the effects of the immune system on bone</title>
<link>http://feeds.nature.com/~r/nrrheum/rss/aop/~3/cGAyqyNLpQg/nrrheum.2009.217</link>
<description>The immune and skeletal systems share several molecules, including cells, cytokines, transcription factors, signaling molecules and membrane receptors. In rheumatoid arthritis, the synovium is a site of active interplay between immune cells and bone cells, in which, as outlined in this Review, osteoclasts are stimulated by cytokines and molecules, such as receptor activator of nuclear factor κB ligand, to mediate structural damage.</description>
<content:encoded><![CDATA[

<p>
<b>Osteoimmunology and the effects of the immune system on bone</b>
</p>
<p>Nature Reviews Rheumatology. <a href="http://dx.doi.org/10.1038/nrrheum.2009.217">doi:10.1038/nrrheum.2009.217</a>
</p>
<p>Author: Hiroshi Takayanagi</p>
<img src="http://feeds.feedburner.com/~r/nrrheum/rss/aop/~4/cGAyqyNLpQg" height="1" width="1"/>]]></content:encoded>
<dc:title>Osteoimmunology and the effects of the immune system on bone</dc:title>
<dc:creator>Hiroshi Takayanagi</dc:creator>
<dc:identifier>doi:10.1038/nrrheum.2009.217</dc:identifier>
<dc:source>Nature Reviews Rheumatology</dc:source>
<dc:date>2009-11-03</dc:date>
<prism:publicationName>Nature Reviews Rheumatology</prism:publicationName>
<prism:publicationDate>2009-11-03</prism:publicationDate>
<prism:doi>10.1038/nrrheum.2009.217</prism:doi>
<prism:url>http://dx.doi.org/10.1038/nrrheum.2009.217</prism:url>
<prism:section>Review</prism:section>
<prism:startingPage />
<prism:endingPage />
<feedburner:origLink>http://dx.doi.org/10.1038/nrrheum.2009.217</feedburner:origLink></item>
</rdf:RDF>
